The Veteran's claim for a higher rating for multiple myeloma was granted from July 27, 2009 to September 6, 2013. From December 16, 2014 to December 9, 2018, he received a 30 percent rating. Beginning on December 9, 2018, the Veteran is again entitled to a total (100 percent) rating for his multiple myeloma.
The deciding factor: The decision was based on the Veteran's residuals of multiple myeloma including fatigue, dyspnea, and recurrent infections which warranted a higher than 30 percent rating under DC 7716 beginning December 9, 2018. The effective date is from December 9, 2018.
- Claimed conditions
- Multiple Myeloma
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 30%
- Decision date
- October 27, 2021
- Citation
- 21065653
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 21065653.
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Remanded (sent back)
The Veteran's multiple myeloma is rated as noncompensable, and the Board has determined that the disability picture does not adequately contemplate his symptoms of fatigue. The VA examiner noted marked interference with employment due to fatigue. Therefore, the claim for an increased rating is remanded for consideration of extraschedular considerations.
- Granted
The Veteran's death was caused by multiple myeloma, which is presumed to be related to his exposure to herbicide agents in Thailand during the Vietnam War. The Board granted service connection for the cause of the Veteran's death based on this presumption.
- Remanded (sent back)
The Veteran's claim for TDIU prior to December 2023 is remanded due to the presence of a 100% disability rating for multiple myeloma starting from December 21, 2023. The Board finds that the Veteran has not met the schedular criteria for a schedular TDIU rating and refers the case for extraschedular consideration.
- Remanded (sent back)
The Board has remanded the claims for service connection for fatigue, dizziness, and chronic kidney disease secondary to the Veteran's service-connected multiple myeloma due to a pre-decisional duty-to-assist error.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.